According to Wired, U.S. biotechnology startup Exin Therapeutics has revealed that its AI agent autonomously selected the gene therapy vector, target brain region, and stereotactic coordinates in experiments, and successfully delivered drugs to the brains of epilepsy model mice using a motorized surgical device.